Skip to main content

Reporter Sept 13 2013

Fishing for new anti-cancer drugs

Sep. 18, 2013—Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

Read more


Mapping brain membrane proteins

Sep. 16, 2013—New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.

Read more


Cancer nanomedicines on target

Sep. 13, 2013—Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time.

Read more


VU study identifies DNA changes in drug-resistant cancer cells

Sep. 12, 2013—Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.

Read more


Federal grant bolsters pulmonary fibrosis research

Sep. 12, 2013—Lisa Young, M.D., associate professor of Pediatrics and Medicine and Cell Biology, has been awarded a five-year, $1.9 million National Institutes of Health grant to study what causes cellular dysfunction and pulmonary fibrosis in patients with Hermansky-Pudlak syndrome (HPS).

Read more


New rounds series focuses on supporting caregivers

Sep. 12, 2013—Bedside Matters, a new hourlong, monthly rounds geared toward helping all Vanderbilt University Medical Center health care providers deal with the social and emotional issues of caring for patients and families, will begin this month.

Read more


VU tracking drug’s ability to prevent type 1 diabetes

Sep. 12, 2013—Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

Read more


Two named to National Academies’ advisory board

Sep. 12, 2013—Vanderbilt University’s Roger D. Cone, Ph.D., and Elizabeth Heitman, Ph.D., have been appointed to the National Academies’ Board on Life Sciences, which advises the government and scientific community on a wide range of topics, from stem cell research to bioterrorism.

Read more


Discovery lecturer to discuss genetic information’s challenges

Sep. 12, 2013—Wylie Burke, M.D., Ph.D., an expert in the social, ethical and policy implications of genetic information, will deliver the next Flexner Discovery Lecture on Thursday, Sept. 19.

Read more


Champ’s Corner Store open for business

Sep. 12, 2013—Building on an already successful venture to offer a variety of safety products to patients and families, the Monroe Carell Jr. Children’s Hospital at Vanderbilt has expanded its Safety Store to become Champ’s Corner Store.

Read more


Sleep education helps families of children with autism

Sep. 12, 2013—Parent sleep education is beneficial in improving sleep and aspects of daytime behavior and family functioning in children with autism spectrum disorders (ASD), according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.

Read more


Nobel laureate Beutler to speak at VU Sept. 23

Sep. 12, 2013—Nobel laureate Bruce Beutler, M.D., will discuss his research on innate immunity during a noon seminar Monday, Sept. 23, in 208 Light Hall.

Read more


Page 1 of 212

Recent Stories from VUMC News and Communications Publications

Brighter days ahead

Vanderbilt Medicine

Brighter days ahead

Community care

Vanderbilt Nurse

Community care

Survive and thrive

Hope

Survive and thrive

Combating cancer disparities is an out-of-office assignment

Momentum

Combating cancer disparities is an out-of-office assignment

more